Clinical trial

Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity

NCT07778693

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-09-01

PhasePHASE3

Study timeline

Study start (estimated)2026-09-01Date precision: day

Registry last updated2026-08-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Overweight , Obesityunresolved

Interventions

MWN109 1DRUG

MWN109 2DRUG

MWN109 3DRUG

PlaceboDRUG

Sponsors & collaborators

Shanghai Minwei Biotechnology Co., Ltdlead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07778693 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.